Today's Information

Provided by: All Cosmos Bio-Tech Holding Corporation
SEQ_NO 1 Date of announcement 2022/07/13 Time of announcement 19:29:37
Subject
 The board of directors of the company resolved to
issue the first unsecured domestic convertible
corporate bonds
Date of events 2022/07/13 To which item it meets paragraph 11
Statement
1.Date of the board of directors resolution:2022/07/13
2.Name [issue no.__ of (secured, unsecured) corporate bonds of
___________ (company)]:
All Cosmos Bio-Tech Holding Corporation
The first unsecured domestic convertible corporate bonds
3.Whether to adopt shelf registration (Yes/No):No
4.Total amount issued:
The total denomination of the issue is NT$500 million
5.Face value per bond:
NT$100,000
6.Issue price:
Issued at 101%~101.5% of the face value
7.Issuance period:Three years
8.Coupon rate:
The coupon rate is 0% per annum
9.Types, names, monetary values and stipulations of collaterals:
Not applicable
10.Use of the funds raised by the offering and utilization plan:
Replenish working capital
11.Underwriting method:
Underwriter will make public sales by way of enquiry and encirclement
12.Trustees of the corporate bonds:
Authorize the chairman of the board to deal with it
13.Underwriter or agent:
Authorize the chairman of the board to deal with it
14.Guarantor(s) for the issuance:
It is an unsecured domestic convertible corporate bonds, so it is not
applicable.
15.Agent for payment of the principal and interest:
Authorize the chairman of the board to deal with it
16.Certifying institution:
It is the issue of intangible securities so it is not applicable
17.Where convertible into shares, the rules for conversion:
Relevant measures will be handled in accordance with relevant laws and
regulations, and will be reported to the relevant competent authorities
for approval and announced separately
18.Sell-back conditions:
Relevant measures will be handled in accordance with relevant laws and
regulations, and will be reported to the relevant competent authorities
for approval and announced separately
19.Buyback conditions:
Relevant measures will be handled in accordance with relevant laws and
regulations, and will be reported to the relevant competent authorities
for approval and announced separately
20.Reference date for any additional share exchange, stock swap, or
subscription:
Relevant measures will be handled in accordance with relevant laws and
regulations, and will be reported to the relevant competent authorities
for approval and announced separately
21.Possible dilution of equity in case of any additional share exchange,
stock swap, or subscription:
Relevant measures will be handled in accordance with relevant laws and
regulations, and will be reported to the relevant competent authorities
for approval and announced separately
22.Any other matters that need to be specified:
1.Due to the rapid changes in the financing environment of the
capital market, in order to grasp the time limit for setting
the issuance conditions and the actual issuance operation, the content
of this first issued domestic unsecured convertible corporate bond,
including issue time, issue amount, issue price, issue conditions,
issuance and conversion methods related to the conversion of corporate
bonds, projects for the funds, the source of funds, the progress of the
use of funds,the expected benefits and other related matters, if
instructed by the competent authority, relevant laws and regulations are
amended, or when the objective environment needs to be revised or amended
authorize the chairman of the board to deal with it.
2.In order to handle this fund raising operation, it is proposed to
authorize the chairman of the board to sign all relevant contracts and
documents on behalf of the company, and to fully handle the unfinished
matters

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

All Cosmos Bio-Tech Holding Corporation published this content on 13 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 July 2022 11:33:00 UTC.